Showing results (601-610 of 914) with videos related to
Sort By:
Pageof 92
Medicine and Science in Sports and Exercise|October 28, 2017
Risk and Causes of Death among Former National Football League Players (1986-2012)Andrew E Lincoln, Robert A Vogel, Thomas W Allen, et al.Experimental and Clinical Psychopharmacology|November 4, 2021
Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced studyKirsten E Smith, Kelly E Dunn, Oliver Grundmann, et al.IEEE Reviews in Biomedical Engineering|March 18, 2022
The Application of Nanotechnology for Quantification of Circulating Tumour DNA in Liquid Biopsies: A Systematic ReviewNathan J W Wu, Matthew Aquilina, Bin-Zhi Qian, et al.Pharmacology Research & Perspectives|December 16, 2014
Differential analysis of transient increases of serum cTnI in response to handling in ratsIgor Mikaelian, Michael E Dunn, Diane R Mould, et al.Frontiers in Psychiatry|April 11, 2022
Making Family-Centered Care for Adults in the ICU a RealityAnn C Schwartz, Sarah E Dunn, Hannah F M Simon, et al.Psychological Trauma : Theory, Research, Practice and Policy|May 1, 2025
Drug misuse, self-esteem, and intimate partner violence among low-income African American womenShujing Zhang, Jennifer Grant, Aniket Malhotra, et al.Medical Care|June 18, 1998
Cross-cultural differences in the reporting of global functional capacity: an example in cataract patientsJ Alonso, C Black, J C Norregaard, et al.The Analyst|June 24, 2004
Development of an in situ fiber optic Raman system to monitor hydrothermal ventsTina M Battaglia, Eileen E Dunn, Marvin D Lilley, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 21, 2021
Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain modelKelly E Dunn, Cecilia L Bergeria, Andrew S Huhn, et al.Journal of Substance Use and Addiction Treatment|October 30, 2025
Identifying patterns of withdrawal among patients in treatment for opioid use disorder: A secondary latent class growth analysis of the CTN XBOT trialNoel Vest, Christina E Freibott, Kelly E Dunn, et al.Pageof 92